Proove Genomics is a controversial pharmacogenomics company attempting a relaunch (July 2024) following a 2017 collapse, FBI raids, and a 2023 dismissal of criminal charges against its founder. While the company possesses a significant historical dataset (153k patients), the submission contains blatantly false claims (e.g., 'most people have used my product', audience is 'everyone') and confusing metrics ('all time marketcap'). The scientific validity of its tests has been historically questioned by experts (e.g., STAT News investigations). The low score reflects the severe credibility gap in the submission and the 'restarting' nature of the business despite its historical scale.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline